6 results
6-K
CNTB
Connect Biopharma Holdings Ltd
30 Dec 22
Connect Biopharma Provides Business and Clinical Development Program Update
8:00am
quarter of 2023 to discuss the Company’s CBP-201 data package.
The information in the paragraphs above under “Information Contained in this Report on Form
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
30 Dec 22
Connect Biopharma Provides Business and Clinical Development Program Update
8:00am
quarter of 2023 to discuss the Company’s CBP-201 data package for a potential NDA filing as early as 2024 and potential approval in China as early
DRSLTR
CNTB
Connect Biopharma Holdings Ltd
26 Jan 21
Correspondence regarding draft registration statement
12:00am
Statement. For your convenience, we are providing by overnight delivery a courtesy package that includes a copy of the Amendment, which has been marked
20-F
eqmwvp1ntocfd8r
31 Mar 22
Annual report (foreign)
4:33pm
- Prev
- 1
- Next